Cargando…
Doxorubicin resistant cancer cells activate myeloid-derived suppressor cells by releasing PGE(2)
Chemotherapies often induce drug-resistance in cancer cells and simultaneously stimulate proliferation and activation of Myeloid-Derived Suppressor Cells (MDSCs) to inhibit anti-tumor T cells, thus result in poor prognosis of patients with breast cancers. To date, the mechanism underlying the expans...
Autores principales: | Rong, Yuan, Yuan, Chun-Hui, Qu, Zhen, Zhou, Hu, Guan, Qing, Yang, Na, Leng, Xiao-Hua, Bu, Lang, Wu, Ke, Wang, Fu-Bing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4817121/ https://www.ncbi.nlm.nih.gov/pubmed/27032536 http://dx.doi.org/10.1038/srep23824 |
Ejemplares similares
-
Key role of the positive feedback between PGE(2) and COX2 in the biology of myeloid-derived suppressor cells
por: Obermajer, Nataŝa, et al.
Publicado: (2012) -
Finasteride Enhances the Generation of Human Myeloid-Derived Suppressor Cells by Up-Regulating the COX2/PGE(2) Pathway
por: Zhang, Shaoying, et al.
Publicado: (2016) -
Myeloid-derived suppressor cells and pulmonary hypertension
por: Zhang, Hui, et al.
Publicado: (2023) -
Exosomes released by granulocytic myeloid-derived suppressor cells attenuate DSS-induced colitis in mice
por: Wang, Yungang, et al.
Publicado: (2016) -
Targeted inhibition of myeloid-derived suppressor cells in the tumor microenvironment by low-dose doxorubicin to improve immune efficacy in murine neuroblastoma
por: Xu, Wei-Li, et al.
Publicado: (2021)